Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL716801 | 0.80 | ALDH1A1 (0.39) | ALDH1A1CYP1A2 | |
| SCHEMBL8098659 | 0.79 | ALDH1A1 (0.48) | ALDH1A1CYP1A2TSHRSMN1; SMN2GRIN2D | |
| SCHEMBL13786 | 0.73 | ALDH1A1 (0.56) | ALDH1A1CYP1A2TSHRSMN1; SMN2POLB | |
| SCHEMBL822281 | 0.73 | ALDH1A1 (0.44) | ALDH1A1CYP1A2TSHRSMN1; SMN2GRIN2D | |
| SCHEMBL3459159 | 0.73 | ALDH1A1 (0.44) | ALDH1A1CYP1A2TSHRSMN1; SMN2GRIN2D | |
| SCHEMBL569156 | 0.73 | ALDH1A1 (0.56) | ALDH1A1CYP1A2TSHRSMN1; SMN2POLB | |
| SCHEMBL1273981 | 0.73 | ALDH1A1 (0.44) | ALDH1A1CYP1A2TSHRSMN1; SMN2GRIN2D | |
| SCHEMBL6257968 | 0.73 | ALDH1A1 (0.44) | ALDH1A1CYP1A2TSHRSMN1; SMN2GRIN2D | |
| SCHEMBL7216820 | 0.73 | ALDH1A1 (0.44) | ALDH1A1CYP1A2TSHRSMN1; SMN2GRIN2D | |
| SCHEMBL4618339 | 0.73 | ALDH1A1 (0.44) | ALDH1A1CYP1A2TSHRSMN1; SMN2GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070079722-A1 | Chemiluminescent paint projectiles and method and preparation | THE SEPRON COMPANY, L.C. | 2007-04-12 | — | — | US | claimed |
| WO-2005040288-A2 | CHEMILUMINESCENT PAINT PROJECTILES AND METHOD OF PREPARATION | THE SEPRON COMPANY, L.C. (US) | 2005-05-06 | — | — | WO | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | claimed |
| EP-0414730-B1 | Chemical Compounds and pharmaceutical compositions capable of releasing a drug | MILLS RANDELL L (US) | 1999-12-15 | — | — | EP | claimed |
| US-5773592-A | COMPRISES A CHEMILUMINESCENT MOIETY, A PHOTOCHROMIC MOIETY AND A BIOLOGICALLY ACTIVE AGENT CAPABLE OF BEING RELEASED | MILLS RANDELL LEE (US) | 1998-06-30 | — | — | US | claimed |
| US-9431675-B2 | Material consisting of composite oxide particles, method for preparing same, and use thereof as electrode active material | HYDRO-QUEBEC (CA) | 2016-08-30 | — | — | US | disclosed |
| US-8647876-B2 | Oxygen permeability measuring apparatus and method, and defect inspection apparatus and method | FUJIFILM CORPORATION (JP) | 2014-02-11 | — | — | US | disclosed |
| US-20120237833-A1 | MATERIAL CONSISTING OF COMPOSITE OXIDE PARTICLES, METHOD FOR PREPARING SAME, AND USE THEREOF AS ELECTRODE ACTIVE MATERIAL | HYDRO-QUEBEC (CA) | 2012-09-20 | — | — | US | disclosed |
| US-20110244577-A1 | OXYGEN PERMEABILITY MEASURING APPARATUS AND METHOD, AND DEFECT INSPECTION APPARATUS AND METHOD | FUJIFILM CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20070079722-A1 | Chemiluminescent paint projectiles and method and preparation | THE SEPRON COMPANY, L.C. | 2007-04-12 | — | — | US | disclosed |
| WO-2005040288-A2 | CHEMILUMINESCENT PAINT PROJECTILES AND METHOD OF PREPARATION | THE SEPRON COMPANY, L.C. (US) | 2005-05-06 | — | — | WO | disclosed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | disclosed |
| US-20050014276-A1 | For gas, liquid, and aersol samples; diabetes; respiratory system analysis | ICB INSTITUTE FUER CHEMO-UND BIOSENSORIK GMBH (DE) | 2005-01-20 | — | — | US | disclosed |
| US-6555663-B1 | Pharmaceuticals which are activated intracellularly by reaction with cellular electron carriers or free radicals to cause release of a free and active drug molecule | MILLS RANDELL LEE (US) | 2003-04-29 | — | — | US | disclosed |
| US-5773592-A | COMPRISES A CHEMILUMINESCENT MOIETY, A PHOTOCHROMIC MOIETY AND A BIOLOGICALLY ACTIVE AGENT CAPABLE OF BEING RELEASED | MILLS RANDELL LEE (US) | 1998-06-30 | — | — | US | disclosed |
| US-5428163-A | Luminides; chemiluminescence; redox system, releasing free drug | MILLS RANDELL L (US) | 1995-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | ALDH1A1 61/4885CYP1A2 214/4885TSHR 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.